The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

M. Kim, L. A. Sumerel, N. Belousova, G. R. Lyons, D. E. Carey, V. Krasnykh, J. T. Douglas

Research output: Contribution to journalArticle

Abstract

The coxsackievirus and adenovirus receptor (CAR) is a membrane glycoprotein with a cytoplasmic domain, a transmembrane domain and an extracellular region consisting of two immunoglobulin-like domains, an amino-terminal immunoglobulin variable (IgV)-related domain (D1), which is distal to the cell surface, and a proximal IgC2 domain (D2). The coxsackievirus and adenovirus receptor has been shown to exhibit tumour suppression activity in human bladder and prostate cancer cells. In the current paper, we demonstrate that CAR is a tumour suppressor in glioma cells and that the extracellular D2 domain is not required for this inhibitory effect. This finding provides a biological basis for the observation that expression of CAR is downregulated in malignant glioma cells. This suggests that strategies to redirect adenoviruses to achieve CAR-independent infection will be necessary to realise the full potential of adenoviral vectors for cancer gene therapy.

Original languageEnglish (US)
Pages (from-to)1411-1416
Number of pages6
JournalBritish Journal of Cancer
Volume88
Issue number9
DOIs
StatePublished - May 6 2003
Externally publishedYes

Fingerprint

Enterovirus
Glioma
Neoplasms
Neoplasm Genes
Membrane Glycoproteins
Urinary Bladder Neoplasms
Adenoviridae
Human Activities
Genetic Therapy
Immunoglobulins
Prostatic Neoplasms
Down-Regulation
adenovirus receptor
Infection

Keywords

  • CAR
  • Glioma
  • Tumour suppressor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. / Kim, M.; Sumerel, L. A.; Belousova, N.; Lyons, G. R.; Carey, D. E.; Krasnykh, V.; Douglas, J. T.

In: British Journal of Cancer, Vol. 88, No. 9, 06.05.2003, p. 1411-1416.

Research output: Contribution to journalArticle

Kim, M, Sumerel, LA, Belousova, N, Lyons, GR, Carey, DE, Krasnykh, V & Douglas, JT 2003, 'The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells', British Journal of Cancer, vol. 88, no. 9, pp. 1411-1416. https://doi.org/10.1038/sj.bjc.6600932
Kim, M. ; Sumerel, L. A. ; Belousova, N. ; Lyons, G. R. ; Carey, D. E. ; Krasnykh, V. ; Douglas, J. T. / The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. In: British Journal of Cancer. 2003 ; Vol. 88, No. 9. pp. 1411-1416.
@article{f618d4dc957d4e00934707c369efc989,
title = "The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells",
abstract = "The coxsackievirus and adenovirus receptor (CAR) is a membrane glycoprotein with a cytoplasmic domain, a transmembrane domain and an extracellular region consisting of two immunoglobulin-like domains, an amino-terminal immunoglobulin variable (IgV)-related domain (D1), which is distal to the cell surface, and a proximal IgC2 domain (D2). The coxsackievirus and adenovirus receptor has been shown to exhibit tumour suppression activity in human bladder and prostate cancer cells. In the current paper, we demonstrate that CAR is a tumour suppressor in glioma cells and that the extracellular D2 domain is not required for this inhibitory effect. This finding provides a biological basis for the observation that expression of CAR is downregulated in malignant glioma cells. This suggests that strategies to redirect adenoviruses to achieve CAR-independent infection will be necessary to realise the full potential of adenoviral vectors for cancer gene therapy.",
keywords = "CAR, Glioma, Tumour suppressor",
author = "M. Kim and Sumerel, {L. A.} and N. Belousova and Lyons, {G. R.} and Carey, {D. E.} and V. Krasnykh and Douglas, {J. T.}",
year = "2003",
month = "5",
day = "6",
doi = "10.1038/sj.bjc.6600932",
language = "English (US)",
volume = "88",
pages = "1411--1416",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells

AU - Kim, M.

AU - Sumerel, L. A.

AU - Belousova, N.

AU - Lyons, G. R.

AU - Carey, D. E.

AU - Krasnykh, V.

AU - Douglas, J. T.

PY - 2003/5/6

Y1 - 2003/5/6

N2 - The coxsackievirus and adenovirus receptor (CAR) is a membrane glycoprotein with a cytoplasmic domain, a transmembrane domain and an extracellular region consisting of two immunoglobulin-like domains, an amino-terminal immunoglobulin variable (IgV)-related domain (D1), which is distal to the cell surface, and a proximal IgC2 domain (D2). The coxsackievirus and adenovirus receptor has been shown to exhibit tumour suppression activity in human bladder and prostate cancer cells. In the current paper, we demonstrate that CAR is a tumour suppressor in glioma cells and that the extracellular D2 domain is not required for this inhibitory effect. This finding provides a biological basis for the observation that expression of CAR is downregulated in malignant glioma cells. This suggests that strategies to redirect adenoviruses to achieve CAR-independent infection will be necessary to realise the full potential of adenoviral vectors for cancer gene therapy.

AB - The coxsackievirus and adenovirus receptor (CAR) is a membrane glycoprotein with a cytoplasmic domain, a transmembrane domain and an extracellular region consisting of two immunoglobulin-like domains, an amino-terminal immunoglobulin variable (IgV)-related domain (D1), which is distal to the cell surface, and a proximal IgC2 domain (D2). The coxsackievirus and adenovirus receptor has been shown to exhibit tumour suppression activity in human bladder and prostate cancer cells. In the current paper, we demonstrate that CAR is a tumour suppressor in glioma cells and that the extracellular D2 domain is not required for this inhibitory effect. This finding provides a biological basis for the observation that expression of CAR is downregulated in malignant glioma cells. This suggests that strategies to redirect adenoviruses to achieve CAR-independent infection will be necessary to realise the full potential of adenoviral vectors for cancer gene therapy.

KW - CAR

KW - Glioma

KW - Tumour suppressor

UR - http://www.scopus.com/inward/record.url?scp=0038146845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038146845&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6600932

DO - 10.1038/sj.bjc.6600932

M3 - Article

C2 - 12778071

AN - SCOPUS:0038146845

VL - 88

SP - 1411

EP - 1416

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 9

ER -